{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113762.1.4.1234.75",
  "meta" : {
    "versionId" : "6",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail" : {
        "name" : "BEST System Author"
      }
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2024-04-04"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2022-01-06"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.75",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113762.1.4.1234.75"
    }
  ],
  "version" : "20220106",
  "name" : "COVID19VaccineICD10PCSCodesForExposureIdentification",
  "title" : "COVID19 vaccine ICD10PCS codes for exposure identification",
  "status" : "active",
  "experimental" : false,
  "date" : "2022-01-06T01:02:20-05:00",
  "publisher" : "BEST System Steward",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: COVID-19 vaccine ICD10PCS codes for identification of potential biologics-related adverse events.),(Data Element Scope: This value set may use a model element in the QDM category of Procedure/Intervention, Immunization, Medication, or Substance.),(Inclusion Criteria: COVID-19 vaccine ICD10PCS codes.),(Exclusion Criteria: None)",
  "compose" : {
    "include" : [
      {
        "system" : "http://www.cms.gov/Medicare/Coding/ICD10",
        "concept" : [
          {
            "code" : "XW013S6",
            "display" : "Introduction of COVID-19 Vaccine Dose 1 into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6"
          },
          {
            "code" : "XW013T6",
            "display" : "Introduction of COVID-19 Vaccine Dose 2 into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6"
          },
          {
            "code" : "XW013U6",
            "display" : "Introduction of COVID-19 Vaccine into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6"
          },
          {
            "code" : "XW023S6",
            "display" : "Introduction of COVID-19 Vaccine Dose 1 into Muscle, Percutaneous Approach, New Technology Group 6"
          },
          {
            "code" : "XW023T6",
            "display" : "Introduction of COVID-19 Vaccine Dose 2 into Muscle, Percutaneous Approach, New Technology Group 6"
          },
          {
            "code" : "XW023U6",
            "display" : "Introduction of COVID-19 Vaccine into Muscle, Percutaneous Approach, New Technology Group 6"
          }
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:092a593c-9d69-45cd-9529-b881fa8e4f2b",
    "timestamp" : "2024-11-08T22:46:41-05:00",
    "total" : 6,
    "contains" : [
      {
        "system" : "http://www.cms.gov/Medicare/Coding/ICD10",
        "version" : "2025",
        "code" : "XW013S6",
        "display" : "Introduction of COVID-19 Vaccine Dose 1 into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6"
      },
      {
        "system" : "http://www.cms.gov/Medicare/Coding/ICD10",
        "version" : "2025",
        "code" : "XW013T6",
        "display" : "Introduction of COVID-19 Vaccine Dose 2 into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6"
      },
      {
        "system" : "http://www.cms.gov/Medicare/Coding/ICD10",
        "version" : "2025",
        "code" : "XW013U6",
        "display" : "Introduction of COVID-19 Vaccine into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6"
      },
      {
        "system" : "http://www.cms.gov/Medicare/Coding/ICD10",
        "version" : "2025",
        "code" : "XW023S6",
        "display" : "Introduction of COVID-19 Vaccine Dose 1 into Muscle, Percutaneous Approach, New Technology Group 6"
      },
      {
        "system" : "http://www.cms.gov/Medicare/Coding/ICD10",
        "version" : "2025",
        "code" : "XW023T6",
        "display" : "Introduction of COVID-19 Vaccine Dose 2 into Muscle, Percutaneous Approach, New Technology Group 6"
      },
      {
        "system" : "http://www.cms.gov/Medicare/Coding/ICD10",
        "version" : "2025",
        "code" : "XW023U6",
        "display" : "Introduction of COVID-19 Vaccine into Muscle, Percutaneous Approach, New Technology Group 6"
      }
    ]
  }
}
